Moderna
MRNA
MRNA
779 hedge funds and large institutions have $17.2B invested in Moderna in 2024 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 254 increasing their positions, 321 reducing their positions, and 215 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
45% less capital invested
Capital invested by funds: $31.1B → $17.2B (-$13.9B)
46% less funds holding in top 10
Funds holding in top 10: 13 → 7 (-6)
72% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 215
Holders
779
Holding in Top 10
7
Calls
$926M
Puts
$1.46B
Top Buyers
| 1 | +$122M | |
| 2 | +$99.3M | |
| 3 | +$79.4M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$72.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$60.6M |
Top Sellers
| 1 | -$435M | |
| 2 | -$253M | |
| 3 | -$100M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$66.2M |
| 5 |
Goldman Sachs
New York
|
-$54M |